Microvascular decompression of the cochleovestibular nerve for treatment of tinnitus and vertigo

Autor: Minke J C van den Berge, Nynke Smidt, Rolien Free, Iris A Posthumus, Pim van Dijk, J. Marc C. van Dijk
Jazyk: angličtina
Rok vydání: 2017
Předmět:
medicine.medical_specialty
COCHLEAR NERVE
microvascular decompression
SYMPTOMS
SURGERY
medicine.medical_treatment
Microvascular decompression
vertigo
03 medical and health sciences
0302 clinical medicine
8TH CRANIAL NERVE
neurovascular conflict
Trigeminal neuralgia
Internal medicine
Vertigo
VASCULAR-DECOMPRESSION
medicine
otorhinolaryngologic diseases
Humans
TYPEWRITER TINNITUS
tinnitus
030223 otorhinolaryngology
functional neurosurgery
biology
business.industry
Standard treatment
SELECTION CRITERIA
General Medicine
Evidence-based medicine
Trigeminal Neuralgia
Vestibulocochlear Nerve
NEUROVASCULAR COMPRESSION SYNDROMES
medicine.disease
biology.organism_classification
PARTICIPANT DATA
Microvascular Decompression Surgery
Surgery
DISABLING POSITIONAL VERTIGO
Systematic review
cochleovestibular nerve
Meta-analysis
medicine.symptom
business
030217 neurology & neurosurgery
Tinnitus
Zdroj: Journal of Neurosurgery. 127(3):588-601
ISSN: 0022-3085
Popis: OBJECTIVEMicrovascular decompression (MVD) is regarded as a valid treatment modality in neurovascular conflicts (NVCs) causing, for example, trigeminal neuralgia and hemifacial spasms. An NVC of the cochleovestibular nerve might cause tinnitus and/or vertigo; however, general acceptance of MVD for this indication is lacking. The aim of this study was to investigate the effectiveness, safety, and prognostic factors for success of MVD of the cochleovestibular nerve.METHODSA systematic review and meta-analysis of individual patient data (IPD) were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Individual Patient Data (PRISMA-IPD) guidelines. By a comprehensive search (conducted in January 2016) in MEDLINE, EMBASE, and Google Scholar, eligible studies were identified. The collected outcome was a global measurement of improvement of 1) tinnitus, 2) vertigo, and 3) tinnitus combined with vertigo. For the meta-analysis, IPD were collected from the papers and/or from the authors. IPD were analyzed with logistic regression analysis while accounting for study clustering.RESULTSThirty-five studies (572 patients) were included. The level of evidence provided by these studies was low. In 28% of patients with tinnitus and 32% of patients with vertigo, complete relief following MVD was reported. Patients with both tinnitus and vertigo had complete relief in 62% of cases. In 11% of patients, ≥ 1 complications were reported. Meta-analysis of IPD (165 patients) demonstrated that patients with both tinnitus and vertigo had a higher chance of success (OR 3.8, 95% CI 1.45–10.10) than patients with tinnitus alone. No other variables were significantly related to success.CONCLUSIONSDue to low success rates, MVD cannot be considered as a standard treatment method for tinnitus or vertigo. Moreover, a substantial complication rate was found. However, patients with combined symptoms had a higher chance of success. When combined symptoms occur, it is more likely that an NVC is the underlying pathology and MVD might be appropriate. Due to the low level of evidence in the included studies, this conclusion must be taken with caution. Further validation is necessary to evaluate whether patients with combined symptoms are indeed better candidates for MVD.
Databáze: OpenAIRE